Ophthalmology Biologics Market Report

China Ophthalmology Biologics Industry Market Research Report 2023-2029

  • POSTDATE：Aug 23, 2023
  • PAGES：229
  • REPORT CODE：GMM1751797
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Ophthalmology Biologics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Allergan

    • Bristol-Myers Squibb

    • Swedish Orphan Biovitrum

    • Ocular Therapeutix

    • Genentech

    • Janssen Biotech

    • Alimera Sciences

    • Bausch & Lomb

    • AbbVie

    • UCBCares

    By Type:

    • Others

    • Ranibizumab

    • Adalimumab

    • Aflibercep

    By Application:

    • Diabetic Macular Edema

    • Macular Degeneration

    • Diabetic Retinopathy

    • Others

    • Uveitis

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Ophthalmology Biologics Market Overview 2018-2029

    • 1.1 China Ophthalmology Biologics Industry Development Overview

    • 1.2 China Ophthalmology Biologics Industry Development History

    • 1.3 China Ophthalmology Biologics Industry Market Size (2018-2029)

    • 1.4 China Ophthalmology Biologics Market Analysis by Type from Production Side

      • 1.4.1 China Ophthalmology Biologics Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.2 China Ophthalmology Biologics Production Volume, Production Value and Growth Rate of Ranibizumab (2018-2029)

      • 1.4.3 China Ophthalmology Biologics Production Volume, Production Value and Growth Rate of Adalimumab (2018-2029)

      • 1.4.4 China Ophthalmology Biologics Production Volume, Production Value and Growth Rate of Aflibercep (2018-2029)

    • 1.5 China Ophthalmology Biologics Market Analysis by Application from Consumption End

      • 1.5.1 China Ophthalmology Biologics Sales Volume, Sales Value and Growth Rate of Diabetic Macular Edema (2018-2029)

      • 1.5.2 China Ophthalmology Biologics Sales Volume, Sales Value and Growth Rate of Macular Degeneration (2018-2029)

      • 1.5.3 China Ophthalmology Biologics Sales Volume, Sales Value and Growth Rate of Diabetic Retinopathy (2018-2029)

      • 1.5.4 China Ophthalmology Biologics Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.5 China Ophthalmology Biologics Sales Volume, Sales Value and Growth Rate of Uveitis (2018-2029)

    • 1.6 China Ophthalmology Biologics Market Analysis by Region

      • 1.6.1 North China Ophthalmology Biologics Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Ophthalmology Biologics Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Ophthalmology Biologics Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Ophthalmology Biologics Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Ophthalmology Biologics Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Ophthalmology Biologics Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Ophthalmology Biologics Market Size and Growth Rate from 2018-2029

    Chapter 2 China Ophthalmology Biologics Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Ophthalmology Biologics Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Ophthalmology Biologics Market Status and Competition Analysis in 2023

      • 2.2.3 China Ophthalmology Biologics Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Ophthalmology Biologics Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Ophthalmology Biologics Industry Development

    Chapter 3 Ophthalmology BiologicsIndustry Chain Analysis

    • 3.1 Ophthalmology Biologics Industry Chain

    • 3.2 Ophthalmology Biologics Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Ophthalmology Biologics Market

    • 3.3 Ophthalmology Biologics Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Ophthalmology Biologics Market

    Chapter 4 China Ophthalmology Biologics Market, by Type

    • 4.1 China Ophthalmology Biologics Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Ophthalmology Biologics Total Production Volume and Growth Rate from Production Side

    • 4.5 China Ophthalmology Biologics Production Volume and Growth Rate, by Type

      • 4.5.1 China Ophthalmology Biologics Production Volume and Growth Rate of Others

      • 4.5.2 China Ophthalmology Biologics Production Volume and Growth Rate of Ranibizumab

      • 4.5.3 China Ophthalmology Biologics Production Volume and Growth Rate of Adalimumab

      • 4.5.4 China Ophthalmology Biologics Production Volume and Growth Rate of Aflibercep

    Chapter 5 China Ophthalmology Biologics Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Ophthalmology Biologics Total Market Size and Growth Rate from Consumption End

    • 5.5 China Ophthalmology Biologics Market Size and Growth Rate, by Application

      • 5.5.1 China Ophthalmology Biologics Market Size and Growth Rate of Diabetic Macular Edema

      • 5.5.2 China Ophthalmology Biologics Market Size and Growth Rate of Macular Degeneration

      • 5.5.3 China Ophthalmology Biologics Market Size and Growth Rate of Diabetic Retinopathy

      • 5.5.4 China Ophthalmology Biologics Market Size and Growth Rate of Others

      • 5.5.5 China Ophthalmology Biologics Market Size and Growth Rate of Uveitis

    Chapter 6 China Ophthalmology Biologics Market, by Region

    • 6.1 China Ophthalmology Biologics Production Volume and Production Value, by Region

    • 6.2 China Ophthalmology Biologics Sales Volume and Sales Value, by Region

    Chapter 7 North China Ophthalmology Biologics Market Analysis

    • 7.1 North China Ophthalmology Biologics Market, by Type

    • 7.2 North China Ophthalmology Biologics Market, by Application

    Chapter 8 Central China Ophthalmology Biologics Market Analysis

    • 8.1 Central China Ophthalmology Biologics Market, by Type

    • 8.2 Central China Ophthalmology Biologics Market, by Application

    Chapter 9 South China Ophthalmology Biologics Market Analysis

    • 9.1 South China Ophthalmology Biologics Market, by Type

    • 9.2 South China Ophthalmology Biologics Market, by Application

    Chapter 10 East China Ophthalmology Biologics Market Analysis

    • 10.1 East China Ophthalmology Biologics Market, by Type

    • 10.2 East China Ophthalmology Biologics Market, by Application

    Chapter 11 Northeast China Ophthalmology Biologics Market Analysis

    • 11.1 Northeast China Ophthalmology Biologics Market, by Type

    • 11.2 Northeast China Ophthalmology Biologics Market, by Application

    Chapter 12 Southwest China Ophthalmology Biologics Market Analysis

    • 12.1 Southwest China Ophthalmology Biologics Market, by Type

    • 12.2 Southwest China Ophthalmology Biologics Market, by Application

    Chapter 13 Northwest China Ophthalmology Biologics Market Analysis

    • 13.1 Northwest China Ophthalmology Biologics Market, by Type

    • 13.2 Northwest China Ophthalmology Biologics Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Allergan

        • 14.1.1 Allergan Company Profile

        • 14.1.2 Allergan Ophthalmology Biologics Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Bristol-Myers Squibb

        • 14.2.1 Bristol-Myers Squibb Company Profile

        • 14.2.2 Bristol-Myers Squibb Ophthalmology Biologics Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Swedish Orphan Biovitrum

        • 14.3.1 Swedish Orphan Biovitrum Company Profile

        • 14.3.2 Swedish Orphan Biovitrum Ophthalmology Biologics Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Ocular Therapeutix

        • 14.4.1 Ocular Therapeutix Company Profile

        • 14.4.2 Ocular Therapeutix Ophthalmology Biologics Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Genentech

        • 14.5.1 Genentech Company Profile

        • 14.5.2 Genentech Ophthalmology Biologics Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Janssen Biotech

        • 14.6.1 Janssen Biotech Company Profile

        • 14.6.2 Janssen Biotech Ophthalmology Biologics Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Alimera Sciences

        • 14.7.1 Alimera Sciences Company Profile

        • 14.7.2 Alimera Sciences Ophthalmology Biologics Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Bausch & Lomb

        • 14.8.1 Bausch & Lomb Company Profile

        • 14.8.2 Bausch & Lomb Ophthalmology Biologics Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 AbbVie

        • 14.9.1 AbbVie Company Profile

        • 14.9.2 AbbVie Ophthalmology Biologics Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 UCBCares

        • 14.10.1 UCBCares Company Profile

        • 14.10.2 UCBCares Ophthalmology Biologics Market Performance

        • 14.10.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Ophthalmology Biologics Industry Research Conclusions

    • 15.2 Ophthalmology Biologics Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Ophthalmology Biologics Industry Market Size (2018-2029)

    • Figure China Ophthalmology Biologics Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Ophthalmology Biologics Production Volume, Production Value and Growth Rate of Ranibizumab (2018-2029)

    • Figure China Ophthalmology Biologics Production Volume, Production Value and Growth Rate of Adalimumab (2018-2029)

    • Figure China Ophthalmology Biologics Production Volume, Production Value and Growth Rate of Aflibercep (2018-2029)

    • Figure China Ophthalmology Biologics Sales Volume, Sales Value and Growth Rate of Diabetic Macular Edema (2018-2029)

    • Figure China Ophthalmology Biologics Sales Volume, Sales Value and Growth Rate of Macular Degeneration (2018-2029)

    • Figure China Ophthalmology Biologics Sales Volume, Sales Value and Growth Rate of Diabetic Retinopathy (2018-2029)

    • Figure China Ophthalmology Biologics Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Ophthalmology Biologics Sales Volume, Sales Value and Growth Rate of Uveitis (2018-2029)

    • Figure North China Ophthalmology Biologics Market Size and Growth Rate from 2018-2029

    • Figure Central China Ophthalmology Biologics Market Size and Growth Rate from 2018-2029

    • Figure South China Ophthalmology Biologics Market Size and Growth Rate from 2018-2029

    • Figure East China Ophthalmology Biologics Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Ophthalmology Biologics Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Ophthalmology Biologics Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Ophthalmology Biologics Market Size and Growth Rate from 2018-2029

    • Figure Ophthalmology Biologics Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Ophthalmology Biologics Market Share by Type in 2018

    • Figure China Ophthalmology Biologics Market Share by Type in 2023

    • Figure China Ophthalmology Biologics Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Ophthalmology Biologics Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Ophthalmology Biologics Production Volume and Growth Rate of Ranibizumab (2018-2023)

    • Figure China Ophthalmology Biologics Production Volume and Growth Rate of Adalimumab (2018-2023)

    • Figure China Ophthalmology Biologics Production Volume and Growth Rate of Aflibercep (2018-2023)

    • Figure China Ophthalmology Biologics Market Share by Application in 2018

    • Figure China Ophthalmology Biologics Market Share by Application in 2023

    • Figure China Ophthalmology Biologics Total Market Size and Growth Rate from Consumption End

    • Figure China Ophthalmology Biologics Market Size and Growth Rate of Diabetic Macular Edema (2018-2023)

    • Figure China Ophthalmology Biologics Market Size and Growth Rate of Macular Degeneration (2018-2023)

    • Figure China Ophthalmology Biologics Market Size and Growth Rate of Diabetic Retinopathy (2018-2023)

    • Figure China Ophthalmology Biologics Market Size and Growth Rate of Others (2018-2023)

    • Figure China Ophthalmology Biologics Market Size and Growth Rate of Uveitis (2018-2023)

    • Table China Ophthalmology Biologics Production Volume by Region (2018-2023)

    • Table China Ophthalmology Biologics Production Volume Share by Region (2018-2023)

    • Figure China Ophthalmology Biologics Production Volume Share by Region (2018-2023)

    • Table China Ophthalmology Biologics Production Value by Region (2018-2023)

    • Table China Ophthalmology Biologics Production Value Share by Region (2018-2023)

    • Figure China Ophthalmology Biologics Production Value Share by Region (2018-2023)

    • Table China Ophthalmology Biologics Sales Volume by Region (2018-2023)

    • Table China Ophthalmology Biologics Sales Volume Share by Region (2018-2023)

    • Figure China Ophthalmology Biologics Sales Volume Share by Region (2018-2023)

    • Table China Ophthalmology Biologics Sales Value by Region (2018-2023)

    • Table China Ophthalmology Biologics Sales Value Share by Region (2018-2023)

    • Figure China Ophthalmology Biologics Sales Value Share by Region (2018-2023)

    • Table North China Ophthalmology Biologics Production Volume by Type (2018-2023)

    • Table North China Ophthalmology Biologics Production Volume Share by Type (2018-2023)

    • Figure North China Ophthalmology Biologics Production Volume Share by Type (2018-2023)

    • Table North China Ophthalmology Biologics Sales Volume by Application (2018-2023)

    • Table North China Ophthalmology Biologics Sales Volume Share by Application (2018-2023)

    • Figure North China Ophthalmology Biologics Sales Volume Share by Application (2018-2023)

    • Table Central China Ophthalmology Biologics Production Volume by Type (2018-2023)

    • Table Central China Ophthalmology Biologics Production Volume Share by Type (2018-2023)

    • Figure Central China Ophthalmology Biologics Production Volume Share by Type (2018-2023)

    • Table Central China Ophthalmology Biologics Sales Volume by Application (2018-2023)

    • Table Central China Ophthalmology Biologics Sales Volume Share by Application (2018-2023)

    • Figure Central China Ophthalmology Biologics Sales Volume Share by Application (2018-2023)

    • Table South China Ophthalmology Biologics Production Volume by Type (2018-2023)

    • Table South China Ophthalmology Biologics Production Volume Share by Type (2018-2023)

    • Figure South China Ophthalmology Biologics Production Volume Share by Type (2018-2023)

    • Table South China Ophthalmology Biologics Sales Volume by Application (2018-2023)

    • Table South China Ophthalmology Biologics Sales Volume Share by Application (2018-2023)

    • Figure South China Ophthalmology Biologics Sales Volume Share by Application (2018-2023)

    • Table East China Ophthalmology Biologics Production Volume by Type (2018-2023)

    • Table East China Ophthalmology Biologics Production Volume Share by Type (2018-2023)

    • Figure East China Ophthalmology Biologics Production Volume Share by Type (2018-2023)

    • Table East China Ophthalmology Biologics Sales Volume by Application (2018-2023)

    • Table East China Ophthalmology Biologics Sales Volume Share by Application (2018-2023)

    • Figure East China Ophthalmology Biologics Sales Volume Share by Application (2018-2023)

    • Table Northeast China Ophthalmology Biologics Production Volume by Type (2018-2023)

    • Table Northeast China Ophthalmology Biologics Production Volume Share by Type (2018-2023)

    • Figure Northeast China Ophthalmology Biologics Production Volume Share by Type (2018-2023)

    • Table Northeast China Ophthalmology Biologics Sales Volume by Application (2018-2023)

    • Table Northeast China Ophthalmology Biologics Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Ophthalmology Biologics Sales Volume Share by Application (2018-2023)

    • Table Southwest China Ophthalmology Biologics Production Volume by Type (2018-2023)

    • Table Southwest China Ophthalmology Biologics Production Volume Share by Type (2018-2023)

    • Figure Southwest China Ophthalmology Biologics Production Volume Share by Type (2018-2023)

    • Table Southwest China Ophthalmology Biologics Sales Volume by Application (2018-2023)

    • Table Southwest China Ophthalmology Biologics Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Ophthalmology Biologics Sales Volume Share by Application (2018-2023)

    • Table Northwest China Ophthalmology Biologics Production Volume by Type (2018-2023)

    • Table Northwest China Ophthalmology Biologics Production Volume Share by Type (2018-2023)

    • Figure Northwest China Ophthalmology Biologics Production Volume Share by Type (2018-2023)

    • Table Northwest China Ophthalmology Biologics Sales Volume by Application (2018-2023)

    • Table Northwest China Ophthalmology Biologics Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Ophthalmology Biologics Sales Volume Share by Application (2018-2023)

    • Table Allergan Company Profile

    • Table Allergan Ophthalmology Biologics Revenue, Price and Gross (2018-2023)

    • Table Bristol-Myers Squibb Company Profile

    • Table Bristol-Myers Squibb Ophthalmology Biologics Revenue, Price and Gross (2018-2023)

    • Table Swedish Orphan Biovitrum Company Profile

    • Table Swedish Orphan Biovitrum Ophthalmology Biologics Revenue, Price and Gross (2018-2023)

    • Table Ocular Therapeutix Company Profile

    • Table Ocular Therapeutix Ophthalmology Biologics Revenue, Price and Gross (2018-2023)

    • Table Genentech Company Profile

    • Table Genentech Ophthalmology Biologics Revenue, Price and Gross (2018-2023)

    • Table Janssen Biotech Company Profile

    • Table Janssen Biotech Ophthalmology Biologics Revenue, Price and Gross (2018-2023)

    • Table Alimera Sciences Company Profile

    • Table Alimera Sciences Ophthalmology Biologics Revenue, Price and Gross (2018-2023)

    • Table Bausch & Lomb Company Profile

    • Table Bausch & Lomb Ophthalmology Biologics Revenue, Price and Gross (2018-2023)

    • Table AbbVie Company Profile

    • Table AbbVie Ophthalmology Biologics Revenue, Price and Gross (2018-2023)

    • Table UCBCares Company Profile

    • Table UCBCares Ophthalmology Biologics Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US